These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29468726)

  • 1. Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors.
    Boxberg M; Götz C; Haidari S; Dorfner C; Jesinghaus M; Drecoll E; Boskov M; Wolff KD; Weichert W; Haller B; Kolk A
    Histopathology; 2018 Oct; 73(4):559-572. PubMed ID: 29468726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 related stemness maneuvers oral squamous cell carcinoma biology.
    Tandon A; Singh NN; Gulati N
    Indian J Pathol Microbiol; 2022; 65(2):268-273. PubMed ID: 35435358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
    da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
    Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
    Niranjan KC; Raj M; Hallikeri K
    Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
    Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of stem cell biomarker CD44 in oral squamous cell carcinoma and its association with lymph node metastasis and TNM staging.
    Chakraborty S; Suresh TN; Azeem Mohiyuddin SM
    J Cancer Res Ther; 2024 Jul; 20(5):1430-1434. PubMed ID: 39412907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 Variant 6 Expression and Tumor Budding in the Medullary Invasion Front of Mandibular Gingival Squamous Cell Carcinoma Are Predictive Factors for Cervical Lymph Node Metastasis.
    Okuyama K; Fukushima H; Naruse T; Yanamoto S; Tsuchihashi H; Umeda M
    Pathol Oncol Res; 2019 Apr; 25(2):603-609. PubMed ID: 30387013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHH Expression Is Significantly Associated With Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma.
    Cierpikowski P; Lis-Nawara A; Bar J
    Anticancer Res; 2021 Nov; 41(11):5405-5413. PubMed ID: 34732409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
    Ortiz RC; Lopes NM; Amôr NG; Ponce JB; Schmerling CK; Lara VS; Moyses RA; Rodini CO
    J Oral Pathol Med; 2018 Sep; 47(8):740-747. PubMed ID: 29791975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of CD44 as a diagnostic and prognostic tool in oral cancer.
    Emich H; Chapireau D; Hutchison I; Mackenzie I
    J Oral Pathol Med; 2015 Jul; 44(6):393-400. PubMed ID: 25640063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.
    Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA
    Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative assessment of CD44-mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma.
    Morand GB; Ikenberg K; Vital DG; Cardona I; Moch H; Stoeckli SJ; Huber GF
    Head Neck; 2019 Apr; 41(4):950-958. PubMed ID: 30561155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system.
    Boxberg M; Jesinghaus M; Dorfner C; Mogler C; Drecoll E; Warth A; Steiger K; Bollwein C; Meyer P; Wolff KD; Kolk A; Weichert W
    Histopathology; 2017 Jun; 70(7):1125-1137. PubMed ID: 28122134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
    Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
    Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSC
    Ortiz RC; Amôr NG; Saito LM; Santesso MR; Lopes NM; Buzo RF; Fonseca AC; Amaral-Silva GK; Moyses RA; Rodini CO
    Sci Rep; 2024 May; 14(1):10583. PubMed ID: 38719848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma.
    Lee HJ; Kang YH; Lee JS; Byun JH; Kim UK; Jang SJ; Rho GJ; Park BW
    BMC Oral Health; 2015 Dec; 15(1):153. PubMed ID: 26626427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.